24-hour levodopa-carbidopa intestinal gel may reduce troublesome dyskinesia in advanced Parkinson’s disease

Levodopa-carbidopa intestinal gel (LCIG) is effective for the control of motor fluctuations in Parkinson’s disease (PD). The objective of this study is to report the reduction of dyskinesias after transitioning from 16 to 24-h/day LCIG infusion. From a cohort of 74 PD patients treated with LCIG for...

Descripción completa

Detalles Bibliográficos
Autores principales: Cruse, Belinda, Morales-Briceño, Hugo, Chang, Florence C F, Mahant, Neil, Ha, Ainhi D, Kim, Samuel D, Wolfe, Nigel, Kwan, Vu, Tsui, David S, Griffith, Jane M, Galea, Donna, Fung, Victor S C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6243994/
https://www.ncbi.nlm.nih.gov/pubmed/30480087
http://dx.doi.org/10.1038/s41531-018-0070-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6243994/
https://www.ncbi.nlm.nih.gov/pubmed/30480087
http://dx.doi.org/10.1038/s41531-018-0070-4

Ejemplares similares